The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Hydroxy-3-(4-((3-(1-(4-methylbenzyl)piperidin-4-yl)-1,2,4-oxadiazol-5-yl)methoxy)phenyl)acrylamide ID: ALA4475118
PubChem CID: 141764824
Max Phase: Preclinical
Molecular Formula: C25H28N4O4
Molecular Weight: 448.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CN2CCC(c3noc(COc4ccc(/C=C/C(=O)NO)cc4)n3)CC2)cc1
Standard InChI: InChI=1S/C25H28N4O4/c1-18-2-4-20(5-3-18)16-29-14-12-21(13-15-29)25-26-24(33-28-25)17-32-22-9-6-19(7-10-22)8-11-23(30)27-31/h2-11,21,31H,12-17H2,1H3,(H,27,30)/b11-8+
Standard InChI Key: SUOLWJGIAOBIJL-DHZHZOJOSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
30.8840 -11.6141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7012 -11.6141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9556 -10.8373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2926 -10.3552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6339 -10.8373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9224 -10.4254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6588 -10.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3708 -10.8222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0741 -10.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7847 -10.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4875 -10.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4792 -9.5756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7622 -9.1748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0623 -9.5926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9254 -9.6023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2180 -9.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5031 -9.5971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.5001 -10.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2120 -10.8366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7975 -9.1849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8016 -8.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1819 -9.1585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8945 -9.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5972 -9.1414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3098 -9.5415 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.5874 -8.3243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.3197 -10.3586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.5123 -7.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5168 -7.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8106 -6.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0985 -7.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0975 -7.9611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8137 -5.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
5 6 1 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
6 15 1 0
6 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
17 20 1 0
20 21 1 0
12 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
24 26 2 0
25 27 1 0
21 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 21 1 0
30 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 448.52Molecular Weight (Monoisotopic): 448.2111AlogP: 3.86#Rotatable Bonds: 8Polar Surface Area: 100.72Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.58CX Basic pKa: 8.27CX LogP: 3.83CX LogD: 3.06Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: -1.38
References 1. Yang Z, Shen M, Tang M, Zhang W, Cui X, Zhang Z, Pei H, Li Y, Hu M, Bai P, Chen L.. (2019) Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy., 178 [PMID:31177073 ] [10.1016/j.ejmech.2019.05.089 ]